| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |